BRAF and neoplasm: In these cases, BRAF p.V600E was identified in three of six samples containing psammoma bodies (without viable tumor cells) (Table 2, Figure 1b, and Figure 2); in all three cases, BRAF p.V600E was also present in the PTC (Table S1).